Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CPI-006
CPI-006
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Pharmaceutical Business Review
Wed, 07/8/20 - 10:34 am
Corvus Pharmaceuticals
clinical trials
immunotherapy
COVID-19
CPI-006